Immunological changes during specific immunotherapy of grass pollen allergy: Reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Ph1 p 1, a major grass pollen allergen

Clinical and Experimental Allergy

Volumn 27, Issue 9, 1997, Pages 1007-1015

  Ebner, C ^a,c   Siemann, U ^a   Bohle, B ^a   Willheim, M ^a   Wiedermann, U ^a   Schenk, S ^a   Klotz, F ^b   Ebner, H ^b   Kraft, D ^a   Scheiner, O ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b Allergy Clinic Reumannplatz   (Austria)

^c Institute of General and Experimental Pathology   (Austria)

Author keywords

Allergy; Immunotherapy; TH1; TH2

Indexed keywords

ALUTARD; CD8 ANTIGEN; CYTOKINE; EPITOPE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G;

ADULT; ANTIBODY TITER; ANTIGEN RECOGNITION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DESENSITIZATION; EPITOPE MAPPING; FEMALE; GRASS POLLEN; HELPER CELL; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE PROLIFERATION; MALE; MOLECULAR CLONING; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; POLLEN ALLERGY; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ADULT; ALLERGENS; CELL LINE; CYTOKINES; DESENSITIZATION, IMMUNOLOGIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; FEMALE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNOBLOTTING; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; LYMPHOCYTE ACTIVATION; MALE; PLANT PROTEINS; POACEAE; POLLEN; T-LYMPHOCYTE SUBSETS; TH1 CELLS; TH2 CELLS; TIME FACTORS; TREATMENT OUTCOME;

EID: 9844266243     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.1997.tb01252.x     Document Type: Article

References (44)

1. Noon L. Prophylactic inoculation against hay fever. Lancet 1911; i:1572-3.
2. Creticos PS, Franklin-Adkinson H Jr, Kager-Sobotka A et al. Nasal challenge with ragweed in hayfever patients: Effect of immunotherapy. J Clin Invest 1985; 76:2247-53.
3. Varney VA, Hamid QA, Gaga M et al. Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by anti-allergic drugs. BMJ 1991; 302:265-9.
4. Bousquet J, Backer WM, Hejjaoui I et al. Differences in clinical and immunological reactivity of patients allergic to grass pollen and to multiple-pollen species. II. Efficacy of a double blind placebo controlled, specific immunotherapy with standardized extracts. J Allergy Clin Immunol 1991; 88:43-53.
5. Djurup R. The subclass and nature of the IgG antibody response in patients undergoing allergen specific immunotherapy. Allergy 1985; 40:469-86.
6. Birkner T, Rumpold H, Jarolira E et al. Evaluation of immunotherapy-induced changes in specific IgE, IgG, and IgG-sub-classes in birch pollen allergic patients by means of immunoblotting. Allergy 1989; 45:418-25.
7. Müller U, Helbling A, Bischof M. Predictive value of venom-specific IgE, IgG and IgG subclass antibodies in patients on immunotherapy with honey bee venom. Allergy 1989; 44:412-8.
8. Brunei C, Bédard PM, Lavoie A, Jobin M, Hérbert J. Allergicrhinitis to ragweed pollen. I. Reassessment of the effects of immunotherapy on cellular and humoral responses. J Allergy Clin Immunol 1992; 89:76-86.
9. Ebner C, Kraft D, Ebner H. Booster immunotherapy (BIT). Allergy 1994; 49:38-42.
10. Djurup R, Mailing HJ. High IgG4 antibody level is associated with failure of immunotherapy with inhalant allergens. Clin Allergy 1987; 17:459-67.
11. Otusaka H, Mezawa A, Ohnishi M, Okubo K, Seki H, Okuda M. Changes in nasal metachromatic cells during allergen immunotherapy. Clin Exp Allergy 1991; 21:115-20.
12. Furin MJ, Norman PS, Creticos PS, Proud D, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM. Immunotherapy decreases antigen-induced eosinophil migration into the nasal cavity. J Allergy Clin Immunol 1991; 88:27-32.
13. Rak S, Lowhagen O, Venge P. The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen allergic patients. J Allergy Clin Immunol 1988; 82:470-80.
14. Rocklin RE, Sheffer AL, Greineder DR, Melmon KL. Generation of antigen-specific supressor cells during allergy desensitization. N Engl J Med 1980; 302:1213-9.
15. Mosmann TR, Coffman RL. Heterogeneity of cytokine secretion patterns and function of T helper cells. Adv Immunol 1989; 46:111-47.
16. Wierenga AE, Snoek M, DeGroot C, Chrétien I, Bos JD, Jansen HM, Kapsenberg ML. Evidence for compartmentalization of functional subsets of CD4 + T lymphocytes in atopic patients. J Immunol 1990; 144:4651-56.
17. Romagnani S. Human Th1 and Th2: doubt no more. Immunol Today 1991; 12:256-7.
18. Parronchi P, Macchia D, Picchini MP, Biswas P, Simonelli C, Maggi E, Ricci M, Ansari A, Romagnani S. Allergen and bacterial antigen-specific T cell clones established from atopic donors show a different profile of cytokine production. Proc Natl Acad Sci USA 1991; 88:4538-46.
19. Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, Corrigan CJ, Durham SR, Kay AB. Predominant TH2-type bronchoalveolar lavage T-lymphocyte population in atopic asthma. New Engl J Med 1992; 326:298-307.
20. Van der Heijden F, Wierenga E, Bos J, Kapsenberg ML. High frequency of IL-4 producing allergen-specific T lymphocytes in atopic dermatitis lesional skin. J Invest Dermatol 1991; 97:389-95.
21. Secrist H, Chelen CJ, Wen Y, Marshall JD, Umetsu DT. Allergen immunotherapy decreases interleukin 4 production in CD4 + T cells from allergic individuals. J Exp Med 1993; 178:2123-30.
22. Jutel M., Pichler WJ, Skrbic D, Urwyler A, Dahinden C, Müller UR. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFNγ(secretion in specific allergen-stimulated T cell cultures. J Immunol 1995; 154:4187-94.
23. Varney VA, Hamid QA, Gaga M, Ying S, Jacobson M, Frew AJ, Kay AB, Durham SR. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late phase cutaneous responses. J Clin Invest 1993; 92:644-51.
24. Durham SR, Ying S, Varney VA, Jacobson MR, Sudderick RM, Mackay IS, Kay AB, Hamid QA. Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4 + T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-γ. J Allergy Clin Immunol 1996; 97:1356-65.
25. Laffer S, Valenta R, Vrtala S, Susani M, VanRee R, Kraft D, Scheiner O, Duchene M. Complementary DNA cloning of the major allergen Phl p l from timothy grass (Phleum pratense); recombinant Phl p 1 inhibits IgE binding to group 1 allergens from eight different grass species. J Allergy Clin Immunol 1994; 94:689.
26. Schenk S, Breiteneder H, Susani M, Najafian N, Laffer S, Duchene M, Valenta R, Fischer G, Scheiner O, Kraft D, Ebner C. T cell epitopes of Phl p 1, major pollen allergen of timothy grass (Phleum pratense): Evidence for crossreacting and non-crossreacting T cell epitopes within grass group I allergens. J Allergy Clin Immunol 1995; 96:686-96.
27. Mailing HJ, Wecke B. EAACI position paper on allergen immunotherapy. Allergy 1993; 48:9 (Suppl.).
28. Vrtala S, Susani M, Sperr WR, Valent P, Laffer S, Dolecek C, Kraft D, Valenta R. Immunologic characterization of purified recombinant timothy grass pollen (Phleum pratense) allergens (Phl p 1, Phl p. 2, Phl p. 5). J Allergy Clin Immunol 1996; 97:781-7.
29. Rohac M, Birkner T, Reimitzer I, Bohle B, Steiner R, Breitenbach M, Kraft D, Scheiner O, Gabl F, Rumpold H. The immunological relationship of epitopes on major tree pollen allergens. Mol Immunol 1991; 28:897-904.
30. Ebner, C, Schenk S, Najafjan N, Siemann U, Steiner R, F. Fischer G, Hoffmann K, Szépfalusi Z, Scheiner O, Kraft D. Nonallergic individuals recognize the same T cell epitopes of Bet v 1, the major birch pollen allergen, as atopic patients. J Immunol 1995; 154:1932-40.
31. Hsieh KH. Changes of lymphoproliferative responses of T cell subsets to allergen and mitogen after hyposensitization in asthmatic children. J Allergy Clin Immunol 74:34-40.
32. Roman P, Möller E. Lymphocyte transformation by grass pollen allergens: a study of atopic patients receiving immunotherapy. Allergy 1988; 43:321-8.
33. Renz H, Lack G, Saloga J, Schwintzer R, Bradley K, Loader J, Kupfer A, Larsen GL, Gelfand EW. Inhibition of IgE production and normalization of airways responsiveness by sensitized CD8 T cells in a mouse model of allergen-induced sensitization. J Immunol 1994; 152:351-60.
34. Pernis B. 1993. Do anergic T cells induce suppressor T lymphocytes through idiotypic reactions? Intern Rev Immunol 10:327-35.
35. + cells in myasthenia gravis patients and in healthy controls. J Immunol 1995; 154:1508-1520.
36. Yssel H, Johnson HE, Schneider PV, Wideman J, Terr A, Kastelein R, De Vries JE. T Cell activation-inducing epitopes of the house dust mite allergen Der p I. J Immunol 1992; 148:738-45.
37. Carballido, JM, Carballido-Perrig N, Kägi MK, Meloen RH, Wüthrich, Heusser CH, Blaser K. T cell epitope specificity in human allergic and non-allergic subjects to bee venom phospholipase A2. J Immunol 1993; 150:3582-91.
38. VanNeerven RJJ, Van't Hof W, Ringrose JH, Jansen HM, Aalberse RC, Wierenga EA, Kapsenberg M. T cell epitopes of house dust mite major allergen Der p II. J Immunol 1993; 151:2326-33.
39. Ebner C, Szépfalusi Z, Ferreira F, Jilek A, Valenta R, Parronchi P, Maggi E, Romagnani S, Scheiner O, Kraft D. Identification of multiple T cell epitopes on Bet v I, the major birch pollen allergen, using specific T cell clones and overlapping peptides. J Immunol 1993; 150:1047-54.
40. Van Neerven RJJ, Van de Pol MM, Van Milligen FJ, Janse HM, Aalberse RG, Kapsenberg M. Characterization of cat dander-specific T lymphocytes from atopic patients. J Immunol 1994; 152:4203-10.
41. Spiegelberg HL, Beck L, Stevenson D, Ishioka GY. Recognition of T cell epitopes and lymphokine secretion by ryegrass allergen Lolium perenne-specific human T cell clones. J Immunol 1994; 152:4706-11.
42. Higgins JA, Thorpe CJ, Hayball JD, O'Hehir RE, Lamb JR. Overlapping T-cell epitopes in the group I allergen of Dermatophagoides species restricted by HLA-DP and HLA-DR class II molecules. J Allergy Clin Immunol 1994; 93:891-9.
43. Norman PS. Modern concepts in immunotherapy. Curr Opin Immunol 1993; 5:968-73.
44. Ferreira, F, Hirthenlehner K, Jilek A, Godnic-Cvar J, Breiteneder H, Grimm R, Hoffmann-Sommergruber K, Scheiner O, Kraft D, Breitenbach M, Rheinberger HJ, Ebner C. Dissection of Immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy. J Exp Med 1996; 183:599-609.